glp-1 receptor agonist with dpp-4 inhibitor combination not recommended do combine inhibitors agonists guidance What classes of diabetes GLP-1 receptor agonists and DPP-4
Description
Weight loss averages 60-80% of excess weight

In this trial, individuals who received Wegovy lost 6.2% of their initial body weight compared to those who received a placebo
Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus

[DOI] [PMC free article] [PubMed] [Google Scholar] Mller FS, Hegelund ER
& Iqbal, N

The results of the study supported this, showing that 15 mg of tirzepatide caused a decrease in pro-C3 by Week 26
